Clinical Trial Enablement Longboat focuses on technology solutions that improve site engagement, patient engagement, and protocol compliance for global clinical trials, presenting an opportunity to upsell broader platform adoption, deeper integration with study startup programs, and enhanced patient-centric features.

Strategic Partnerships Recent integration with Advarra indicates a path for co-sell and bundled offerings around study startup and single sign-on, suggesting sales opportunities through integrated workflows and joint marketing with regulatory/compliance partners.

Mobile-First Platform A fully mobile, cloud-based site and patient engagement platform positions Longboat to address remote or decentralized trials, enabling cross-sell of mobile-enabled monitoring, eConsent, virtual visits, and remote patient engagement tools.

Proven Innovation Award recognition for eHealth Innovation and a history of expanding digital tools like Virtual Visit demonstrate momentum and credibility that can help open conversations with trial sponsors seeking modern, efficient trial logistics and digital tooling.

Mid-Sized Growth With 51-200 employees and revenue in the low-to-mid millions, Longboat sits in a target segment for mid-market sponsors seeking cost-effective, scalable solutions, suggesting expansion opportunities with mid-tier pharma and midsize CROs looking to optimize trial operations.